For the 20th MDDS, lectures will be held both online and in-presence.
Courses
Program
The lessons will be done in 2 different section:
- I section focused on the topics of the medicinal chemistry
- II section focused on the industry world
The courses will be followed by a ten-day drug development summer school. More information will be available soon.
Tutor
The tutors of the University Master’s program are the Professors:
- Maurizio Taddei (UNISI)
- Elena Petricci (UNISI)
- Jean-Denis Docquier (UNISI)
- Nicola Dimitri (UNISI)
Lectures
A.Y. 2025/26
Prof. Thierry Langer (University of Wien):
- 1st part: Chemistry Driven Drug Discovery and Pharmacophores
- 2nd part: Hit Identification by using Virtual Screening
Dr. Anna Visibelli (University of Siena): Introduction to Artificial Intelligence: Examples and Applications in Bioinformatics
Dr. Paolo Governa (University of Parma): Essential of Computer-Aided Drug Design: focus on ligandability and molecular similarity
Dr. Diego Fiorucci and Dr. Iuni Trist (Evotec): Polyhedric support to Drug Design
Dr. Andrea Sodini (University of Florence): Stereoselective O- and C-Glycosylation Reactions
Dr. Francesco Milanesi (University of Florence): Synthetic receptors for molecular recognition of carbohydrates: a pragmatic user’s guide
Dr. Lorena Tedeschi (CNR): Bioconjugation techniques for molecular and cellular imaging
Dr. Veronica Ghini (CERM): Metabolomics and drug discovery: general principles and applications in (metallo-) drug research
Dr. Luca Menichetti (CNR): Molecula imaging for drug design
Dr. Filippo Campana (University of Perugia): Green methodologies for the synthesis of pharmaceutically active compounds
Dr. Giulia Brufani (University of Perugia): Green methodologies for the synthesis of pharmaceutically active compounds. Laboratory of E-factor calculation
Prof. Jean-Denis Docquier (University of Siena): Innovation in the discovery and development of antibacterial drugs in the age of antibiotic resistance
Prof. Daniele Castagnolo (University College London):
- 1st part: Sustainability in Medicinal Chemistry and Drug Synthesis
- 2nd part: Introduction to biocatalysis
Dr. Fabio Rancati (Chiesi): Approaches to the development of chemical probes and inhaled drugs
Dr. Mirjam Cugini (MJ Consulting): Tools for Effective Personal and Interpersonal Communication
Dr. Claudia Sala (Fondazione Biotecnopolo di Siena): Drug discovery against tuberculosis
Dr. Simone Mantegazza (Dipharma Francis): From Route Design to Scale-Up: R&D Challenges in API Synthesis
Dr. Chiara Vladiskovic (Dipharma Francis): Polymorphism and solid state: a different challenge for the pharmaceutical industry
Dr. Federica Poggialini (University of Siena): Drug Like Properties in Drug Discovery
Dr. Giuseppina Truglio (University of Siena): Antibody-Drug Conjugates as Targeted Drug Delivery Systems: Beyond Conventional Cytotoxic Payloads
Prof. Marco Lolli and Prof. Stefano Sainas (University of Turin):
- 1st part: The hit to lead process: focus on bioisosterism
- 2nd part: Case history: discovery of human dihydroorotate dehydrogenase (hDHODH) inhibitors using a bioisosteric approach
- 3rd part: Case history: preclinical development of human dihydroorotate dehydrogenase (hDHODH) inhibitors: how (try to) reach the Market
Prof. Walter Cabri (University of Bologna): Greening peptide synthesis
Dr. Giuseppe Giannini: Controlling oral microbiota/periodontitis – oral drugs and their impact on intestinal microbiota
Prof. Daria Bottai (University of Pisa): Antibody-Antibiotic Cojugates to fight bacterial infections: challenges and therapeutic potential
Dr. Francesca Ricci (Fondazione Mario Negri): Preclinical studies in the drug discovery and development processes
Dr. Carla Ferreri (CNR): Free radicals: from chemistry to biology ….generating sciencepreneurship
Prof. Nicola Dimitri (University of Siena): The economics of pharmaceutical research and development